Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Massa

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cellular and Molecular Life Sciences : CMLS|November 5, 2022
Induction of pulmonary HLA-G expression by SARS-CoV-2 infectionBarbara Seliger, Simon Jasinski-Bergner, Chiara Massa, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
Cell Death Discovery|September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibitionDavid Junk, Sebastian Krämer, Johannes Broschewitz, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapyMichael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Journal of Translational Medicine|March 7, 2025
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancersKarthikeyan Subbarayan, Helena Bieber, Chiara Massa, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Cellular and Molecular Life Sciences : CMLS|December 3, 2024
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumorsKarthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, et al.
Oncotarget|April 9, 2016
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinomaSimon Jasinski-Bergner, Adi Reches, Christine Stoehr, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Oncoimmunology|December 2, 2024
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escapeMeron Yohannes, Chiara Massa, Zelalem Desalegn, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cellular and Molecular Life Sciences : CMLS|November 5, 2022
Induction of pulmonary HLA-G expression by SARS-CoV-2 infectionBarbara Seliger, Simon Jasinski-Bergner, Chiara Massa, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
Cell Death Discovery|September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibitionDavid Junk, Sebastian Krämer, Johannes Broschewitz, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapyMichael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Journal of Translational Medicine|March 7, 2025
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancersKarthikeyan Subbarayan, Helena Bieber, Chiara Massa, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Cellular and Molecular Life Sciences : CMLS|December 3, 2024
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumorsKarthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, et al.
Oncotarget|April 9, 2016
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinomaSimon Jasinski-Bergner, Adi Reches, Christine Stoehr, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Oncoimmunology|December 2, 2024
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escapeMeron Yohannes, Chiara Massa, Zelalem Desalegn, et al.
Pageof 5